Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05356702 · ClinicalTrials.gov registry record · NA

The Brain Health Study: A Pragmatic, Patient-Centered Trial

A NA study of Alzheimer Disease and Dementia, sponsored by Kaiser Permanente.

Active
Registry status
NA
Development phase
3,417
Enrollment target
5
Study locations

NCT05356702 is a NA study of Alzheimer Disease and Dementia that is active but no longer recruiting, run by Kaiser Permanente. The registered enrollment target is 3,417 participants, above the 2,740-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (25% higher). The trial reports 5 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05356702, a NA study of Alzheimer Disease and Dementia, is active but no longer recruiting, sponsored by Kaiser Permanente.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
3,417 participants
Enrollment target
5
Study locations

Study Summary

The eRADAR Brain Health Study seeks to refine and test a novel, low-cost strategy for increasing dementia detection within primary care.

Interventions

  • OTHER Brain Health Assessment

Study Locations (5)

Washington

  • Kaiser Permanente Burien Medical Center - Burien
  • Kaiser Permanente Kent Medical Center - Kent
  • Kaiser Permanente Renton Medical Center - Renton
  • Kaiser Permanente, Capitol Hill - Seattle
  • Kaiser Permanente Northgate Medical Center - Seattle

Trial Details

FieldValue
Enrollment Target 3,417 participants
Start Date 2022-06-29
Est. Completion 2025-04-15
Phase NA

Sponsor

Kaiser Permanente

294 total trials

What the Registry Record Tells You About NCT05356702

The ClinicalTrials.gov registry entry for NCT05356702 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 3,417 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,740-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (25% higher). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which Brain Health Assessment is the first listed.

NCT05356702 reports 5 study locations spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT05356702 about?

NCT05356702 is a clinical study titled "The Brain Health Study: A Pragmatic, Patient-Centered Trial". The eRADAR Brain Health Study seeks to refine and test a novel, low-cost strategy for increasing dementia detection within primary care.

What is the current status of trial NCT05356702?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 3,417 participants. The study started on 2022-06-29. Estimated completion is 2025-04-15.

What conditions does trial NCT05356702 study?

This clinical trial studies the following conditions: Alzheimer Disease, Dementia.

What interventions are being tested in trial NCT05356702?

The interventions under investigation include: Brain Health Assessment (OTHER).

Who is sponsoring clinical trial NCT05356702?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05356702 being conducted?

This trial has 5 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.